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Multiple myeloma (MM) is characterized by osteolytic bone lesions, adiacent to tu-
mor foci within bone, that arise as a consequence of osteoblast inactivation and osteo-
clast activation. Canonical Wnt signaling is central to normal bone homeostasis, and 
secretion of Wnt signaling inhibitors by MM cells contributes to MM-related bone de-
struction and disease progression. In this study, we investigated the effects of MM cells 
on osteoblast differentiation and the potential role of Sclerostin, a Wnt signaling antago-
nist, in the inhibition of osteoblastogenesis in MM. In our study, we first showed that 
MM cells expressed Sclerostin at mRNA and protein levels. Moreover, using a co-culture 
system between human bone marrow stromal cells (BMSCs) and MM cells we demon-
strated that MM cells induce an inhibitory effect on alkaline phosphatase, collagen I 
and AP-1 transcription factor expression in BMSCs. This inhibition was reverted by the 
addition of the anti-Sclerostin neutralizing monoclonal antibody. In the co-culture sys-
tem, this antibody also partially rescued the inhibitory effect on BMSC mineralization. 
Moreover, knowing that the Wnt signaling activation affect the RANKL/OPG axis, we 
studied in our co-colture system the effect of the anti-Sclerostin monoclonal antibody on 
the expression of these two cytokines. In particular, we found that human MM cells up-
regulated RANKL expression, but strongly down-regulated OPG production by BMSCs 
at mRNA and protein levels. The presence in the co-culture of the neutralizing antibody 
reduced RANKL and increased OPG expression. Thus, our data indicate that Sclerostin 
could be one of the factors inducing the uncoupling between formation and resorption 
in MM patients by the direct inhibition of osteoblast differentiation and the indirect 
stimulation of osteoclast activity. 
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